13220-17-2 Usage
Uses
Used in Personal Care and Household Products:
1-Methyl-3-pyrrolidinyl Benzoate is used as a fragrance ingredient for its sweet, fruity odor, enhancing the scent profiles of various personal care and household products.
Used in Inks, Coatings, Adhesives, and Cleaning Products:
1-Methyl-3-pyrrolidinyl Benzoate is used as a solvent in these applications due to its solvency properties, which aid in the dispersion and application of these products.
Used in Perfumery:
1-Methyl-3-pyrrolidinyl Benzoate is used as a component in the formulation of perfumes, contributing to the overall scent composition and providing a pleasant aroma.
Used in the Food Industry:
1-Methyl-3-pyrrolidinyl Benzoate is used as a flavoring agent, imparting a sweet, fruity taste to various food products.
Check Digit Verification of cas no
The CAS Registry Mumber 13220-17-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,2,2 and 0 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 13220-17:
(7*1)+(6*3)+(5*2)+(4*2)+(3*0)+(2*1)+(1*7)=52
52 % 10 = 2
So 13220-17-2 is a valid CAS Registry Number.
13220-17-2Relevant academic research and scientific papers
Carry over of impurities: A detailed exemplification for glycopyrrolate (NVA237)
Allmendinger, Thomas,Bixel, Dominique,Clarke, Adrian,Di Geronimo, Laura,Fredy, Jean-Wilfried,Manz, Marco,Gavioli, Elena,Wicky, Regine,Schneider, Martin,Stauffert, Fabien J.,Tibi, Markus,Valentekovic, Darko
supporting information, p. 1754 - 1769 (2013/01/15)
The original synthesis of glycopyrrolate (NVA237) was revised and shortened into an essentially one-pot process. Without isolating the intermediates, their purification became obsolete, thereby increasing the possibility of the carry over of impurities. For that reason, the actual, potential, and theoretical impurities of the starting materials cyclopentyl mandelic acid and 1-methyl-pyrrolidin-3-ol as well as byproducts which may occur during the synthesis were thoroughly investigated; furthermore, their transformation to possible impurities in the drug substance along the new synthetic route was performed to exclude them as actual impurities in the drug substance with certainty. The question is raised how detailed such investigation-which are fairly manageable for a simple product like glycopyrrolate-need to be.
